ID
25529
Description
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Keywords
Versions (3)
- 9/4/17 9/4/17 -
- 9/4/17 9/4/17 -
- 9/5/17 9/5/17 -
Uploaded on
September 5, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
screening physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
screening physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
body area
Data type
text
Alias
- UMLS CUI [1]
- C1268086
Description
status
Data type
text
Alias
- UMLS CUI [1]
- C0449438
Description
abnormality
Data type
text
Alias
- UMLS CUI [1]
- C1704258
Description
Investigator
Alias
- UMLS CUI-1
- C2826892
Similar models
screening physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
C0013443 (UMLS CUI-3)
C0028429 (UMLS CUI-5)
C0230028 (UMLS CUI-7)
C0031354 (UMLS CUI-9)
(Comment:en)
C0040132 (UMLS CUI-3)
(Comment:en)
(Comment:en)
C0024109 (UMLS CUI-3)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0034929 (UMLS CUI-3)
(Comment:en)